Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection
Author
Abstract
Suggested Citation
DOI: 10.1515/fhep-2015-0028
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- David H. Howard & Peter B. Bach & Ernst R. Berndt & Rena M. Conti, 2015.
"Pricing in the Market for Anticancer Drugs,"
Journal of Economic Perspectives, American Economic Association, vol. 29(1), pages 139-162, Winter.
- David H. Howard & Peter B. Bach & Ernst R. Berndt & Rena M. Conti, 2015. "Pricing in the Market for Anticancer Drugs," NBER Working Papers 20867, National Bureau of Economic Research, Inc.
- David M. Cutler, 2008. "Are We Finally Winning the War on Cancer?," Journal of Economic Perspectives, American Economic Association, vol. 22(4), pages 3-26, Fall.
- Sun Eric & Jena Anupam B & Lakdawalla Darius & Reyes Carolina & Philipson Tomas J & Goldman Dana, 2010. "The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000," Forum for Health Economics & Policy, De Gruyter, vol. 13(2), pages 1-22, February.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Kyle, Margaret & Dubois, Pierre, 2016. "The Effects of Pharmaceutical Innovation on Cancer Mortality," CEPR Discussion Papers 11487, C.E.P.R. Discussion Papers.
- Dubois, Pierre & Kyle, Margaret, 2016. "The Effects of Pharmaceutical Innovation on Cancer Mortality Rates," TSE Working Papers 16-688, Toulouse School of Economics (TSE).
- Marianne P. Bitler & Christopher S. Carpenter & Danea Horn, 2021. "Effects of the Colorectal Cancer Control Program," Health Economics, John Wiley & Sons, Ltd., vol. 30(11), pages 2667-2685, November.
- David Laibson, 1997.
"Golden Eggs and Hyperbolic Discounting,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 112(2), pages 443-478.
- Laibson, David I., 1997. "Golden Eggs and Hyperbolic Discounting," Scholarly Articles 4481499, Harvard University Department of Economics.
- Thomas Barnay & Mohamed Ali Ben Halima & Emmanuel Duguet & Christine Le Clainche & Camille Regaert, 2016.
"The effects of breast cancer on individual labour market outcomes: an evaluation from an administrative panel,"
TEPP Working Paper
2016-05, TEPP.
- Thomas Barnay & Mohamed Ali Ben Halima & Emmanuel Duguet & Christine Leclainche & Camille Regaert, 2016. "The Effects Of Breast Cancer On Individual Labour Market Outcomes: An Evaluation From An Administrative Panel," Working Papers halshs-01374467, HAL.
- Thomas Barnay & Emmanuel Duguet & Christine Le Clainche, 2019.
"The Effects of Breast Cancer on Individual Labour Market Outcomes: An Evaluation from an Administrative Panel in France,"
Annals of Economics and Statistics, GENES, issue 136, pages 103-126.
- Thomas Barnay & Emmanuel Duguet & Christine Le Clainche, 2019. "The Effects of Breast Cancer on Individual Labour Market Outcomes: An Evaluation from an Administrative Panel in France," Post-Print hal-02499129, HAL.
- Thomas Barnay & Emmanuel Duguet & Christine Le Clainche, 2019. "The effects of breast cancer on individual labour market outcomes: an evaluation from an administrative panel in France," Erudite Working Paper 2019-12, Erudite.
- Edouard Debonneuil & Anne Eyraud-Loisel & Frédéric Planchet, 2018.
"Can Pension Funds Partially Manage Longevity Risk by Investing in a Longevity Megafund?,"
Risks, MDPI, vol. 6(3), pages 1-27, July.
- Edouard Debonneuil & Anne Eyraud-Loisel & Frédéric Planchet, 2018. "Can Pension Funds Partially Manage Longevity Risk by Investing in a Longevity Megafund?," Post-Print hal-01571937, HAL.
- Howdon, Daniel & Jones, Andrew M., 2015.
"A discrete latent factor model for smoking, cancer and mortality,"
Economics & Human Biology, Elsevier, vol. 18(C), pages 57-73.
- Howdon, D. & Jones, A., 2013. "A discrete latent factor model for smoking, cancer and mortality," Health, Econometrics and Data Group (HEDG) Working Papers 13/14, HEDG, c/o Department of Economics, University of York.
- Salas-Vega, Sebastian & Shearer, Emily & Mossialos, Elias, 2020. "Relationship between costs and clinical benefits of new cancer medicines in Australia, France, the UK, and the US," Social Science & Medicine, Elsevier, vol. 258(C).
- J.-Matthias Schulenburg & Martin Frank, 2015. "Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(2), pages 113-118, March.
- Sabine Vogler & Valérie Paris & Alessandra Ferrario & Veronika J. Wirtz & Kees Joncheere & Peter Schneider & Hanne Bak Pedersen & Guillaume Dedet & Zaheer-Ud-Din Babar, 2017. "How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries," Applied Health Economics and Health Policy, Springer, vol. 15(3), pages 307-321, June.
- Robert Rosenman, 2011.
"The public finance of healthy behavior,"
Public Choice, Springer, vol. 147(1), pages 173-188, April.
- Robert Rosenman, 2009. "The Public Finance of Healthy Behavior," Working Papers 2009-18, School of Economic Sciences, Washington State University.
- David H. Howard & Peter B. Bach & Ernst R. Berndt & Rena M. Conti, 2015.
"Pricing in the Market for Anticancer Drugs,"
Journal of Economic Perspectives, American Economic Association, vol. 29(1), pages 139-162, Winter.
- David H. Howard & Peter B. Bach & Ernst R. Berndt & Rena M. Conti, 2015. "Pricing in the Market for Anticancer Drugs," NBER Working Papers 20867, National Bureau of Economic Research, Inc.
- Cutler, David M. & Lange, Fabian & Meara, Ellen & Richards-Shubik, Seth & Ruhm, Christopher J., 2011. "Rising educational gradients in mortality: The role of behavioral risk factors," Journal of Health Economics, Elsevier, vol. 30(6), pages 1174-1187.
- David M. Cutler & Fabian Lange & Ellen Meara & Seth Richards & Christopher J. Ruhm, 2010. "Explaining the Rise in Educational Gradients in Mortality," NBER Working Papers 15678, National Bureau of Economic Research, Inc.
- Thomas C. Buchmueller & Léontine Goldzahl, 2018. "The Effect of Organized Breast Cancer Screening on Mammography Use: Evidence from France," NBER Working Papers 24316, National Bureau of Economic Research, Inc.
- Lakdawalla, Darius N. & Sun, Eric C. & Jena, Anupam B. & Reyes, Carolina M. & Goldman, Dana P. & Philipson, Tomas J., 2010.
"An economic evaluation of the war on cancer,"
Journal of Health Economics, Elsevier, vol. 29(3), pages 333-346, May.
- Eric C. Sun & Anupam B. Jena & Darius N. Lakdawalla & Carolina M. Reyes & Tomas J. Philipson & Dana P. Goldman, 2009. "An Economic Evaluation of the War on Cancer," NBER Working Papers 15574, National Bureau of Economic Research, Inc.
- Avdic, Daniel & Lundborg, Petter & Vikström, Johan, 2014.
"Learning-by-Doing in a Highly Skilled Profession when Stakes are High: Evidence from Advanced Cancer Surgery,"
Working Paper Series, Center for Labor Studies
2014:9, Uppsala University, Department of Economics.
- Avdic, Daniel & Lundborg, Petter & Vikström, Johan, 2014. "Learning-by-Doing in a Highly Skilled Profession When Stakes Are High: Evidence from Advanced Cancer Surgery," IZA Discussion Papers 8099, Institute of Labor Economics (IZA).
- Avdic, Daniel & Lundborg, Petter & Vikström, Johan, 2014. "Learning-by-doing in a highly skilled profession when stakes are high: evidence from advanced cancer surgery," Working Paper Series 2014:7, IFAU - Institute for Evaluation of Labour Market and Education Policy.
- Michael Chernew & David M. Cutler & Kaushik Ghosh & Mary Beth Landrum, 2016.
"Understanding the Improvement in Disability-Free Life Expectancy in the US Elderly Population,"
NBER Chapters, in: Insights in the Economics of Aging, pages 161-201,
National Bureau of Economic Research, Inc.
- Michael Chernew & David M. Cutler & Kaushik Ghosh & Mary Beth Landrum, 2016. "Understanding the Improvement in Disability Free Life Expectancy In the U.S. Elderly Population," NBER Working Papers 22306, National Bureau of Economic Research, Inc.
- Chatterjee, Chirantan & Gupta, Samarth, 2024. "Public entry and private prices: New evidence from Indian pharmaceutical markets," Journal of Economic Behavior & Organization, Elsevier, vol. 219(C), pages 473-489.
More about this item
Keywords
cancer; cancer screening; cancer treatment; medical innovation;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bpj:fhecpo:v:19:y:2016:i:1:p:141-156:n:6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Peter Golla (email available below). General contact details of provider: https://www.degruyter.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.